GL1X · GenesisL1 explorer

UniProt P26663

P26663

P26663 (UniProt P26663): 170 experimental structures on GenesisL1, 4 ligands bound. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
P26663
Experimental structures
170
Predicted models
0
Ligands
4

Structures

170 records of P26663 in the MolNFT archive: 170 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
1A1QHepatitis C virus NS3 proteinasex-ray diffractionA, B, C——
1A1QHepatitis C virus NS3 proteinasex-ray diffractionA, B, C——
1BT7The solution NMR structure of the N-terminal protease domain of the hepatitis C virus (HCV)…solution nmrA——
1BT7The solution NMR structure of the N-terminal protease domain of the hepatitis C virus (HCV)…solution nmrA——
1C2PHepatitis C virus NS5B RNA-dependent RNA polymerasex-ray diffractionA, B——
1C2PHepatitis C virus NS5B RNA-dependent RNA polymerasex-ray diffractionA, B——
1CSJCrystal structure of the RNA-dependent RNA polymerase of hepatitis C virusx-ray diffractionA, B——
1CSJCrystal structure of the RNA-dependent RNA polymerase of hepatitis C virusx-ray diffractionA, B——
1CU1Crystal structure of an enzyme complex from hepatitis C virusx-ray diffractionA, B——
1CU1Crystal structure of an enzyme complex from hepatitis C virusx-ray diffractionA, B——
1GX5Hepatitis C Virus RNA Polymerase in Complex with GTP and Manganesex-ray diffractionA——
1GX5Hepatitis C virus RNA polymerase in complex with GTP and manganesex-ray diffractionA——
1GX6Hepatitis C Virus RNA polymerase in complex with UTP and manganesex-ray diffractionA——
1GX6Hepatitis C virus RNA polymerase in complex with UTP and manganesex-ray diffractionA——
1JXPBk strain hepatitis C virus (HCV) NS3-NS4Ax-ray diffractionA, C, B, D——
1JXPBk strain hepatitis C virus (HCV) NS3-NS4Ax-ray diffractionA, C, B, D——
1NHUHepatitis C virus RNA polymerase in complex with non-nucleoside analogue inhibitorx-ray diffractionA, B——
1NHUHepatitis C virus RNA polymerase in complex with non-nucleoside analogue inhibitorx-ray diffractionA, B——
1NHVHepatitis C virus RNA polymerase in complex with non-nucleoside analogue inhibitorx-ray diffractionA, B——
1NHVHepatitis C virus RNA polymerase in complex with non-nucleoside analogue inhibitorx-ray diffractionA, B——
1NS3Structure of HCV protease (bk strain)x-ray diffractionA, B, C, D——
1NS3Structure of HCV protease (bk strain)x-ray diffractionA, B, C, D——
1OS5Crystal structure of HCV NS5B RNA polymerase complexed with a novel non-competitive inhibitor.x-ray diffractionA——
1OS5Crystal structure of HCV NS5B RNA polymerase complexed with a novel non-competitive inhibitor.x-ray diffractionA——
1QUVCrystal structure of the RNA directed RNA polymerase of hepatitis C virusx-ray diffractionA——
1QUVCrystal structure of the RNA directed RNA polymerase of hepatitis C virusx-ray diffractionA——
2AWZHepatitis C Virus NS5b RNA Polymerase in complex with a covalent inhibitor (5h)x-ray diffractionA, B——
2AWZHepatitis C virus NS5B RNA polymerase in complex with a covalent inhibitor (5H)x-ray diffractionA, B——
2AX0Hepatitis C Virus NS5b RNA Polymerase in complex with a covalent inhibitor (5x)x-ray diffractionA, B——
2AX0Hepatitis C virus NS5B RNA polymerase in complex with a covalent inhibitor (5X)x-ray diffractionA, B——
2AX1Hepatitis C Virus NS5b RNA Polymerase in complex with a covalent inhibitor (5ee)x-ray diffractionA, B——
2AX1Hepatitis C virus NS5B RNA polymerase in complex with a covalent inhibitor (5EE)x-ray diffractionA, B——
2BRKCrystal structure of Hepatitis C virus polymerase in complex with an allosteric inhibitor (compound…x-ray diffractionA——
2BRKCrystal structure of hepatitis C virus polymerase in complex with an allosteric inhibitor (compound…x-ray diffractionA——
2BRLCrystal structure of Hepatitis C virus polymerase in complex with an allosteric inhibitor (compound…x-ray diffractionA——
2BRLCrystal structure of hepatitis C virus polymerase in complex with an allosteric inhibitor (compound…x-ray diffractionA——
2DXSCrystal structure of HCV NS5B RNA polymerase complexed with a tetracyclic inhibitorx-ray diffractionA, B——
2DXSCrystal structure of HCV NS5B RNA polymerase complexed with a tetracyclic inhibitorx-ray diffractionA, B——
2GIQHepatitis C virus RNA-dependent RNA polymerase NS5B with NNI-2 inhibitorx-ray diffractionA, B——
2GIQHepatitis C virus RNA-dependent RNA polymerase NS5B with nni-2 inhibitorx-ray diffractionA, B——
2GIRHepatitis C virus RNA-dependent RNA polymerase NS5B with NNI-1 inhibitorx-ray diffractionA, B——
2GIRHepatitis C virus RNA-dependent RNA polymerase NS5B with nni-1 inhibitorx-ray diffractionA, B——
2HAICrystal structure of HCV NS5B RNA polymerase in complex with novel class of…x-ray diffractionA——
2HAICrystal structure of HCV NS5B RNA polymerase in complex with novel class of…x-ray diffractionA——
2HWHHCV NS5B allosteric inhibitor complexx-ray diffractionA, B——
2HWHHCV NS5B allosteric inhibitor complexx-ray diffractionA, B——
2HWIHCV NS5B allosteric inhibitor complexx-ray diffractionA, B——
2HWIHCV NS5B allosteric inhibitor complexx-ray diffractionA, B——
2I1RNovel Thiazolones as HCV NS5B Polymerase Inhibitors: Further Designs, Synthesis, SAR and X-ray…x-ray diffractionA, B——
2I1RNovel thiazolones as HCV NS5B polymerase inhibitors: further designs, synthesis, sar and X-ray…x-ray diffractionA, B——
2O5DThiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: Convergence of…x-ray diffractionA, B——
2O5DThiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: convergence of…x-ray diffractionA, B——
2WCXCrystal Structure of Hepatitis C Virus NS5B Polymerase in Complex with Thienopyrrole-Based…x-ray diffractionA——
2WCXCrystal structure of hepatitis C virus NS5B polymerase in complex with thienopyrrole-based…x-ray diffractionA——
2WHOCrystal structure of hepatitis C virus NS5B polymerase from 1B genotype in complex with a…x-ray diffractionA, B——
2WHOCrystal structure of hepatitis C virus NS5B polymerase from 1B genotype in complex with a…x-ray diffractionA, B——
2WRMIdentification of Novel Allosteric Inhibitors of Hepatitis C Virus NS5B Polymerase Thumb Domain…x-ray diffractionA——
2WRMIdentification of novel allosteric inhibitors of hepatitis C virus NS5B polymerase thumb domain…x-ray diffractionA——
2XWYStructure of MK-3281, a Potent Non-Nucleoside Finger-Loop Inhibitor, in complex with the Hepatitis…x-ray diffractionA——
2XWYStructure of mk-3281, a potent non-nucleoside finger-loop inhibitor, in complex with the hepatitis…x-ray diffractionA——

110 records more on the page itself.

Ligands

  • 3VY · (1-methyl-1H-indol-3-yl)acetic acid · in 1 record
  • 9VY · 2-(4-fluorophenyl)-5-(11-fluoro-6H-pyrido[2',3':5,6][1, 3]oxazino[3,4-a]indol-2-yl)-N-methyl-6-[methyl(methylsulfonyl)amino]-1-benzofuran-3-carboxamide · in 1 record
  • K4S · (4-{[5-cyclopropyl-2-(4-fluorophenyl)-3-(methylcarbamoyl)-1-benzofuran-6-yl](methylsulfonyl) amino}phenyl)boronic acid · in 1 record
  • SL4 · 5-[[(2~{S})-4-[1,1-bis(oxidanylidene)-1,2-benzothiazol-3-yl]-2-~{tert}-butyl-3-oxidanyl-5-oxidanylidene-2~{H}-pyrrol-1-yl]methyl]-2-fluoranyl-benzenecarbonitrile · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.